Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Dec 9;37(1):182-188.
doi: 10.1002/joa3.12459. eCollection 2021 Feb.

Impact of a poor functional capacity on the clinical outcomes in patients with a pacemaker implantation -Results from the Japanese Heart Rhythm Society Registry

Takanori Arimoto  1 , Eiichi Watanabe  2 , Ritsuko Kohno  3 , Kenji Shimeno  4 , Kan Kikuchi  5 , Atsushi Doi  6 , Kanki Inoue  7 , Takashi Nitta  8 , Akihiko Nogami  9 , Haruhiko Abe  3 , Ken Okumura  10
Affiliations

Impact of a poor functional capacity on the clinical outcomes in patients with a pacemaker implantation -Results from the Japanese Heart Rhythm Society Registry

Takanori Arimoto et al. J Arrhythm. .

Abstract

Background: Functional capacity (FC) correlates with mortality in various cardiovascular diseases. The aim of this study was to examine whether cardiac pacemaker implantations improve the FC and affect the prognosis.

Methods and results: We prospectively enrolled 621 de novo pacemaker recipients (age 76 ± 9 years, 50.7% male). The FC was assessed by metabolic equivalents (METs) during the implantation and periodically thereafter. The patients were a priori classified into poor FC (<2 METs, n = 40), moderate FC (2 ≤ METs < 4, n = 239), and good FC (≥4 METs, n = 342). Three months after the pacemaker implantation, poor FC or moderate FC patients improved to a good FC by 43%. The distribution of the three FCs remained at those levels until after 1 year of follow-up (P = .18). During a median follow-up of 2.4 years, 71 patients (11%) had cardiovascular hospitalizations and 35 (5.6%) all-cause death. A multivariate Cox analysis revealed that a poor FC at baseline was an independent predictor of both cardiovascular hospitalization (hazard ratio [HR] 2.494, P = .012) and all-cause death (HR 3.338, P = .016). One year after the pacemaker implantation, the eight who remained with a poor FC had a high mortality rate of 37.5% (P < .01).

Conclusion: Approximately half of the poor or moderate FC patients improved to good FC 3 months after the pacemaker implantation. The baseline FC predicted the prognosis, and patients with an improved FC after the pacemaker implantation had a better prognosis.

Keywords: functional capacity; pacemaker; prognosis.

PubMed Disclaimer

Conflict of interest statement

EW received a lecture fee from Biotronik Japan, Daiichi‐Sankyo, and Pfizer. RK has an affiliation with the endowed departments of Boston Scientific and Abbott. AN received a lecture fee from Daiichi‐Sankyo and has an affiliation with the endowed department of Boston Scientific and Abbott. KO received a lecture fee from Johnson and Johnson, Medtronic, Daiichi‐Sankyo, and Boehringer‐Ingelheim. None of the other authors have conflicts of interest.

Figures

FIGURE 1
FIGURE 1
The time course of the functional capacity (FC). (A) Changes in the FC between baseline and 3 months after the pacemaker implantation. Three months after the pacemaker implantation, 43% of those with poor and moderate FC at baseline improved to good FC (16 + 105/40 + 239). During the 3 months follow‐up period, 78 patients were lost because they returned to the hospital or clinic that had been referred after the device implantation. (B) The raw number of FCs during follow‐up. (C) The proportion of three classes of FCs. The patients were a priori classified into poor FC (<2 METs), moderate FC (2 ≤ METs <4), and good FC (≥4 METs). FC = functional capacity, F/U = follow‐up, METs = metabolic equivalents
FIGURE 2
FIGURE 2
Kaplan‐Meier analysis of the time to the subsequent outcome. (A) The cardiovascular hospitalization rate was higher in the patients with poor FC than in those with moderate or good FC. (B) The total mortality rate was higher in the patients with poor FC than in those with moderate FC or good FC. Abbreviations are shown in Figure 1
FIGURE 3
FIGURE 3
Subgroup analysis among the patients with poor functional capacity. (A) Changes in the functional capacity during 1‐year follow‐up. Seven (17.5%) patients improved to moderate FC, and 19 (47.5%) had a marked improvement. Abbreviations are shown in Figure 1. (B) The total mortality rates. A log‐rank test was not applied because no patients with good FC died
See this image and copyright information in PMC

References

    1. Epstein AE, DiMarco JP, Ellenbogen KA, Estes NA 3rd, Freedman RA, Gettes LS, et al. ACC/AHA/HRS 2008 Guidelines for Device‐Based Therapy of Cardiac Rhythm Abnormalities: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): developed in collaboration with the American Association for Thoracic Surgery and Society of Thoracic Surgeons. Circulation. 2008;117:e350–e408. - PubMed
    1. Toff WD, Camm AJ, Skehan JD; United Kingdom Pacing and Cardiovascular Events Trial Investigators . Single‐chamber versus dual‐chamber pacing for high‐grade atrioventricular block. N Engl J Med. 2005;353:145–55. - PubMed
    1. Andersen HR, Nielsen JC, Thomsen PEB, Thuesen L, Mortensen PT, Vesterlund T, et al. Long‐term follow‐up of patients from a randomised trial of atrial versus ventricular pacing for sick‐sinus syndrome. Lancet. 1997;350:1210–6. - PubMed
    1. Tsutsui H, Isobe M, Ito H, Okumura K, Ono M, Kitakaze M, et al. JCS 2017/JHFS 2017 guideline on diagnosis and treatment of acute and chronic heart failure‐ digest version. Circ J. 2019;83:2084–184. - PubMed
    1. Kamiya K, Yamamoto T, Tsuchihashi‐Makaya M, Ikegame T, Takahashi T, Sato Y, et al. Nationwide survey of multidisciplinary care and cardiac rehabilitation for patients with heart failure in Japan ‐ an analysis of the AMED‐CHF study. Circ J. 2019;83:1546–52. - PubMed